Brief: Klaria Re-Acquires Global Rights For Naloxone Project

Klaria Pharma Holding AB (publ)

13/09/2019 07:40

Sept 13 (Reuters) - Klaria Pharma Holding AB (publ)
 KLAR.ST :
    * KLARIA RE-ACQUIRES ALL GLOBAL RIGHTS FOR ITS NALOXONE
PROJECT
FROM PURDUE PHARMA (CANADA)
    * KLARIA ANNOUNCES THAT COMPANY WILL RE-ACQUIRE ALL GLOBAL
RIGHTS
TO NALOXONE ALGINATE FILM (KL-00514) FROM PURDUE PHARMA (CANADA)
    * CONTINUED DEVELOPMENT OF THIS PROJECT FOR ACUTE TREATMENT
OF
OPIOID OVERDOSE WILL NOW CONTINUE WITHIN KLARIA
    * RE-ACQUISITION OF NALOXONE ALGINATE FILM (KL-00514) FROM
PURDUE
PHARMA (CANADA) IS EFFECTIVE IMMEDIATELY AND CARRIES NO FURTHER
FINANCIAL OBLIGATIONS FOR EITHER COMPANY IN RELATION TO THIS
PRODUCT

Source text for Eikon:  ID:nWkr64TbP1 
Further company coverage:  KLAR.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))